4Mulherin DM, Thumham DI, Situnayake-RD, et al. Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. [J]. Ann Rheum Dis, 1996,55( 11 ) :837 - 840.
5Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and mitochondrial DNA mutatiocs: diagnosis and treatment[J]. Annu Rev Nutr, 1994,14: 535 - 568.
6Kerr DS. Protean manifestations of mitochondrial diseases: a minireview[J] .J Pediatr Hematol Oncol, 1997,19(4) :279- 286.
7Ave'yanov AA, Lapikova VP, Nikolaev ON, et al. Active oxygenassociated control of rice blast disease by ~riboflavin and roseoflavin[J]. Biochemistry (Mosc), 2000,65(11):1292- 1298.
8Helveston W,Cibula JE,Hurd R, et al. Abnormalities of antioxidant metabolism in a case of Friedrelch's disease[J]. Clin Neuropharmacol, 1996, 19(3) :271 - 275.
9Morris AA, Leonard JV. The treatment of congenital lactic acidoses[J]. J Inherit Metab Dis, 1996,19(4): 573-580.
10Kodentsova VM, Vrzhesinskaia OA, Trofimenko-EV, et al. Metabolism of some vitamins in children with insulin-dependent diabetes mellitus: importance of the disease duration, severity and metabolism impairment[J] . Vopr Med Khim, 1994,40(4):33-38.
